BIOMAT Database Logo BIOMAT Database Logo

Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. 2007

Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Department of Obstetrics and Gynecology, Johann Wolfgang Goethe University, Frankfurt, Germany.

OBJECTIVE A common characteristic of mammary carcinomas is an inverse relationship between the estrogen receptor (ER) status and the proliferative activity of the tumor. Yet, a subset of ER-positive breast cancers is characterized by a high proliferation, suggesting malfunctions in ER responsiveness that influence the biological and therapeutic behavior of tumor cells. The expression of several ER-dependent genes seems to be dysregulated among those "uncoupled" tumors. One of those genes is plexin B1, a cell-surface receptor for the semaphorin Sema4D (CD 100). However, the biological role of plexin B1 in breast cancer is largely unknown. METHODS Expression data of plexin B1 were obtained from Affymetrix microarray analysis of n = 119 breast cancer specimens. Validation was done by quantitative real-time PCR and protein expression was evaluated by immunohistochemistry. Expression data were compared with clinical characteristics as well as follow-up data of the disease. RESULTS Low plexin B1 expression levels characterize a more aggressive tumor phenotype. The expression of plexin B1 is strongly correlated with the ER status. However, even among ER-positive tumors, loss of plexin B1 is associated with an impaired prognosis of breast cancer patients in both univariate (all patients, P = 0.0062; ER positive, P = 0.0107) and multivariate analyses (all patients, P = 0.032; ER positive, P = 0.022). Immunohistochemistry reveals that the tumor cells themselves and not the endothelial cells are the major source of plexin B1 expression in the tumor. CONCLUSIONS Plexin B1 acts not only as a new important prognostic but should also represent a predictive marker indicating an endocrine resistance. These data give a new insight in markers that could be involved in endocrine dysregulation of breast cancer.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
October 1996, Archives of pathology & laboratory medicine,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers.
December 2014, Hormones & cancer,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
January 2008, Breast cancer research : BCR,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.
October 1986, Journal of the National Cancer Institute,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?
January 1994, Invasion & metastasis,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
October 2008, Clinical cancer research : an official journal of the American Association for Cancer Research,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Molecular classification of estrogen receptor-positive/luminal breast cancers.
January 2012, Advances in anatomic pathology,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Clinicopathological characteristics of estrogen receptor-beta-positive human breast cancers.
October 2001, Japanese journal of cancer research : Gann,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers.
August 2017, eLife,
Achim Rody, and Uwe Holtrich, and Regine Gaetje, and Mathias Gehrmann, and Knut Engels, and Gunter von Minckwitz, and Sibylle Loibl, and Raihanatou Diallo-Danebrock, and Eugen Ruckhäberle, and Dirk Metzler, and Andre Ahr, and Christine Solbach, and Thomas Karn, and Manfred Kaufmann
Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers.
August 2012, Breast cancer research and treatment,
Copied contents to your clipboard!